focus -WSS

focus

author：fashion 2025-09-29 21:12:55 - browse：262

UnitedHealth Group’s Optum subsidiary saw a lower operating margin in the second quarter due to more seniors getting care, a spike in demand for behavioral health services, and an influx of members with higher health needs.

“Those three elements, the senior trend piece, the behavioral piece, and then the effects of the strong growth is really what explains what’s going on,” UnitedHealth Group CEO Andrew Witty said on the company’s earnings call on Friday. “We’ll continue to lean into that growth very assertively.”

Minnetonka, Minn.-based UnitedHealth Group’s Optum segment, which includes its provider arm, its pharmacy benefit manager, and its data and technology arm, reported an operating margin of 6.6% in the quarter ended June 30, compared with 7.3% in the prior-year period. Leaders said the decline was within its provider arm, Optum Health.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Alkermes shareholders re
Next article： Readout Newsletter: CG Oncology IPO, Eli Lilly, Tesla, Merck

WSS

Syphilis numbers in the United States reach record heights

Medicare drug price negotiation legal challenge met with skepticism

Medicare Advantage insurers face 0.2% cut to 2025 payments

Pancreatic cancer early detection could be helped by AI

At Orexo, a ‘turning point’ for everything but digital health

AI can’t replace a physician’s gut feeling

knowledge

focus

leisure time

Alkermes shareholders re

Whistleblower: Blue Cross Blue Shield evaded $170 million in taxes

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Vertex non

New air purifier tech could be key to improving indoor air quality

Investment in vaccine development is lagging, report finds

Hepatitis C has a cure — but many Americans still lack access to it

Merck CEO won’t testify in Senate, citing no expertise in drug prices

Virginia high school admissions case could be legal follow

Cosmetics set for new safety regulation. Why the industry is on board

entertainment

Readout Newsletter: Vertex, Pfizer, Kura, and other biotech news

Pancreatic cancer early detection could be helped by AI

Sanofi seeks simpler, safer CRISPR sickle cell cure

Humana’s losses in Medicare Advantage tank its stock

Readout Newsletter: CG Oncology IPO, Eli Lilly, Tesla, Merck

ARCH Venture Partners tops STAT's 2023 biotech VC rankings

focus

leisure time

hotspot

hotspot